Company Filing History:
Years Active: 2020
Title: Innovations by Kyunggon Kim in Thyroid Cancer Diagnosis
Introduction
Kyunggon Kim is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of medical diagnostics, particularly in the diagnosis of follicular thyroid carcinoma. His innovative approach utilizes protein expression levels to enhance diagnostic accuracy.
Latest Patents
Kyunggon Kim holds a patent for a composition aimed at diagnosing follicular thyroid carcinoma. The patent describes a method that measures the expression levels of aminoacyl-tRNA synthetase-related proteins in thyroid tissue samples from patients suspected of having this type of cancer. By comparing these levels to those in a control group, the method provides a reliable diagnostic marker for the disease.
Career Highlights
Throughout his career, Kyunggon Kim has worked with esteemed organizations such as the Medicinal Bioconvergence Research Center and The Asan Foundation. His work in these institutions has allowed him to focus on innovative research and development in the medical field.
Collaborations
Kyunggon Kim has collaborated with notable colleagues, including Sunghoon Kim and Won Suk Yang. These partnerships have contributed to the advancement of his research and the successful development of his patented methods.
Conclusion
Kyunggon Kim's contributions to the diagnosis of follicular thyroid carcinoma exemplify the impact of innovative research in medicine. His work not only enhances diagnostic capabilities but also paves the way for future advancements in cancer detection.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.